Financial insights of LIMNW

MyFinsight

For the quarter ending 2026-03-31.

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
General and administrative	700,898	238,740.5	701,170	1,118,211
Research and development	400,000	-	-	-
Total operating expenses	1,100,898	238,740.5	701,170	1,118,211
Loss from operations	-1,100,898	-238,740.5*	-701,170	-1,118,211
Interest expense, related parties	18,638	93,893*	19,052	62,288
Interest income	-	3,440*	-	24,383
Forgiveness of unrelated vendor payables	-	-9,164,574*	-	2,142,297
Change in fair value of deferred underwriting fee - paid in common stock	-	98,000*	560,000	-756,000
Change in the fair value of warrant liabilities	4,178	-114,346.5*	-76,871	116,894
Gain on exchange of common stock for warrants	-	3,480,000*	-1,740,000	-
Fair value of common stock to be issued for contingent liability	-	1,840,000*	-	-
Total other expense, net	-22,816	-7,402,680.5*	-1,122,181	1,231,498
Net loss	-1,123,714	-7,641,421	-1,823,351	113,287

Basic EPS	-0.03	-0.365	-0.07	0
Diluted EPS	-0.03	-0.365	-0.07	0
Basic Average Shares	35,999,589	20,951,937	27,007,568	23,301,178
Diluted Average Shares	35,999,589	20,951,937	27,007,568	23,301,178